Journal of Applied Physiology, Vol 70, Issue 1 260-266, Copyright © 1991 by American Physiological Society

ARTICLES

Potent vasoactive properties of endothelin 1 in human skin

D. C. Crossman, S. D. Brain and R. W. Fuller
Section of Vascular Biology, Medical Research Council Clinical Research Centre, Harrow, Middlesex, United Kingdom.

The effect of the endothelial cell-derived peptide endothelin 1 was investigated in human skin. Intradermal injection of endothelin 1 (1-100 pmol) caused a dose-dependent area of pallor that was associated with a significant reduction in basal skin blood flow, measured by laser-Doppler blood flowmeter (with 1 pmol endothelin, P = 0.012, analysis of variance). The coadministration of endothelin 1 (1-100 pmol) with the neuropeptide vasodilator calcitonin gene-related peptide (CGRP) inhibited the vasodilator response to CGRP (10 pmol) by up to 82.7 +/- 9.2% (with 100 pmol endothelin, P less than 0.001). The response of the prostanoid vasodilator prostaglandin E2 (10 pmol) was inhibited by endothelin in a similar manner. In addition to the vasoconstrictor effects, endothelin 1 produced a dose-dependent flare that surrounded the area of pallor, and this was associated with a significant increase in blood flow (P less than 0.05) within the flare area. The H1 antagonist terfenadine (120 mg po) significantly reduced the flare area associated with endothelin 1: flare 5 min after intradermal endothelin (10 pmol, placebo treated), 668 +/- 405 mm2; terfenadine treated, 201 +/- 257 mm2 (P less than 0.05). The flare was also significantly attenuated when endothelin (10 pmol) was injected into local anesthetic-treated skin. Thus intradermal injection of endothelin in humans causes long-lasting vasoconstriction at the site of injection and a surrounding flare. Results suggest that the flare component is partially histamine dependent and the result of an axon reflex. This study demonstrates the potent activity of endothelin in human skin. It is possible that endothelin could be relevant to the local response of skin to injury.

This article has been cited by other articles:

				D. L. Kellogg Jr., Y. Liu, and P. E. Pergola Genome and Hormones: Gender Differences in Physiology: Selected Contribution: Gender differences in the endothelin-B receptor contribution to basal cutaneous vascular tone in humans J Appl Physiol, November 1, 2001; 91(5): 2407 - 2411. [Abstract] [Full Text] [PDF]

				A. P. Gokin, M. U. Fareed, H.-L. Pan, G. Hans, G. R. Strichartz, and G. Davar Local Injection of Endothelin-1 Produces Pain-Like Behavior and Excitation of Nociceptors in Rats J. Neurosci., July 15, 2001; 21(14): 5358 - 5366. [Abstract] [Full Text] [PDF]

				J. E. Lipa, P. C. Neligan, T. M. Perreault, J. Baribeau, R. H. Levine, R. J. Knowlton, and C. Y. Pang Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H359 - H367. [Abstract] [Full Text] [PDF]

				C. Y. Pang, J. Zhang, H. Xu, J. E. Lipa, C. R. Forrest, and P. C. Neligan Role and mechanism of endothelin-B receptors in mediating ET-1-induced vasoconstriction in pig skin Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1066 - R1074. [Abstract] [Full Text] [PDF]

				R. R. Wenzel, N. Duthiers, G. Noll, J. Bucher, U. Kaufmann, and T. F. Luscher Endothelin and Calcium Antagonists in the Skin Microcirculation of Patients With Coronary Artery Disease Circulation, August 1, 1996; 94(3): 316 - 322. [Abstract] [Full Text]

				C. E. Whitworth, M. M. Veniant, J. D. Firth, A. D. Cumming, and J. J. Mullins Endothelin in the Kidney in Malignant Phase Hypertension Hypertension, December 1, 1995; 26(6): 925 - 931. [Abstract] [Full Text]